Conmed Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2019
January 30, 2020 at 02:31 am IST
Share
CONMED Corporation announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced sales was USD 264.865 million compared to USD 242.444 million a year ago. Operating income was USD 27.879 million compared to USD 25.822 million a year ago. Net income was USD 14.933 million compared to USD 15.653 million a year ago. Basic earnings per share was USD 0.53 compared to USD 0.56 a year ago. Diluted earnings per share was USD 0.49 compared to USD 0.54 a year ago. For the full year, sales was USD 955.097 million compared to USD 859.634 million a year ago. Operating income was USD 79.114 million compared to USD 71.305 million a year ago. Net income was USD 28.620 million compared to USD 40.854 million a year ago. Basic earnings per share was USD 1.01 compared to USD 1.45 a year ago. Diluted earnings per share was USD 0.97 compared to USD 1.41 a year ago.
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.